Henk Brulleman Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Portfolio
  • 1

Henk Brulleman General Information


Mr. Henk Brulleman is an Angel Investor. He serves as Board Member at BBB Therapeutics and Biomx. He was a Board Member at 2-BBB. Henk Brulleman studied Business Economics at the Free University in Amsterdam. He started his career at Royal Dutch Shell and rose to the position of deputy chief investment officer. He then became a partner at Numeric Investors LLC, a Boston-based quantitative equity management firm, where he co-managed portfolios with a combined value of $3 billion and handled client relations, marketing, and modeling. After retiring from Numeric, he built a portfolio of several equity and convertible debt stakes, predominantly in the field of life sciences, pharmaceuticals, and medical technology. After five years of retirement, he recently joined Wolkers & Co, a multi-family fiduciary asset management office, as a partner.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 7 Pinhas Sapir Street
  • Floor 2
  • Ness Ziona 7414002
  • Israel
+972 000-000-0000

Henk Brulleman Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000 0 03-Apr-2013 00000 (00000 Aerospace and Defense Generating Revenue
To view Henk Brulleman’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Henk Brulleman Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Henk Brulleman Team (1)

Name Title Deals Funds Boards Office
Henk Brulleman Angel Investor 0 Ness Ziona, Israel
To view Henk Brulleman’s complete team members history, request access »